TransFlex human OAT4 (SLC22A11) plates are available in a 96-well format with variable plate configurations. The plates are ready to use after an overnight incubation—no change of medium required.
In the graph above, TransFlex-OAT4 plate performance is demonstrated by OAT4-mediated transport of estrone 3-sulfate (E3S), and inhibition of that transport by the OAT4 inhibitor indomethacin.
|Catalog Number||Plate Configuration|
|TFlex-OAT4||Half of the wells contain OAT4-expressing cells, and half contain control cells.|
|TFlex-OAT4-F||All of the wells contain OAT4-expressing cells.|
|TFlex-MDCK-C||All of the wells contain control cells.|
|TFlex-Pick2||Custom format: plate contains two transporters of your choice, plus control cells.|
|TFlex-Pick4||Custom format: plate contains four transporters of your choice, plus control cells.|
Please contact us for more information.